Long-term methylphenidate treatment down-regulates c-fos in the striatum of male CD-1 mice

Neuroreport. 2004 Apr 29;15(6):1045-8. doi: 10.1097/00001756-200404290-00022.

Abstract

Methylphenidate (Ritalin) is routinely prescribed to children with attention deficit hyperactivity disorder, but little is known about its long-term consequences on brain development. We treated pre- and peri-pubertal male CD-1 mice with repeated injections of methylphenidate hydrochloride (MPH) and quantified the expression of the immediate early gene c-fos in the striatum. A single injection of MPH (5 or 40 mg/kg) significantly elevated FOS immunoreactivity in the striatum in a dose-dependent manner, compared with saline. Repeated MPH treatment attenuated the effect of a single challenge dose of MPH on striatal c-fos expression. These results replicate those observed with rats and indicate that long-term use of MPH may alter neural activity by down-regulation of gene expression in the striatum.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects*
  • Down-Regulation / physiology
  • Genes, fos / drug effects*
  • Genes, fos / physiology
  • Male
  • Methylphenidate / administration & dosage*
  • Mice
  • Time

Substances

  • Methylphenidate